FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-000233-39-ES
Enrollment
Unknown
Registered
2012-03-14
Start date
2012-05-21
Completion date
Unknown
Last updated
2012-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10000835 Term: Acute leukemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)

Interventions

Trade Name: Zavedos Product Name: Zavedos Product Code: PR 1 Pharmaceutical Form: Powder and solution for solution for injection INN or Proposed INN: IDARUBICIN CAS Number: 58957-92-9 Current Sponsor

Sponsors

Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 45 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 45

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Spain

Contacts

Public ContactRomy Rodriguez

Institut de Recerca HSCSP

rrodriguezmu@santpau.cat349329190001969

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026